Clinical Trials Logo

Filter by:
NCT ID: NCT06024343 Not yet recruiting - Clinical trials for Pancreatic Neuroendocrine Tumor

Minimally Invasive Pancreatic Enucleation With Main Pancreatic Duct Repair or Reconstruction

Start date: September 1, 2023
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the impact of concomitant main pancreatic duct repair or reconstruction during minimally invasive pancreatic tumor enucleation on long-term patient prognosis and quality of life.

NCT ID: NCT06024265 Recruiting - Huntington Disease Clinical Trials

The Safety and Tolerability Study With ER2001 Intravenous Injection in Adults With Early Manifest Huntington's Disease

Start date: April 4, 2023
Phase: Early Phase 1
Study type: Interventional

This is an open label, dose escalation clinic trial of ER2001 intravenous injection to evaluate safety, tolerability and pharmacokinetics of ascending single and multiple doses of intravenously administered ER2001 in patients with early manifest Huntington's Disease. Furthermore, pharmacodynamics in particular target engagement, and early clinical signs of efficacy will be assessed. This study will evaluate increasing doses of ER2001 in sequential cohorts. ER2001 was escalated over 4 dose levels . The planned duration of this treatment is 14 weeks.

NCT ID: NCT06024200 Recruiting - Clinical trials for Transcutaneous Electrical Acupoint Stimulation

Transcutaneous Electrical Acupoint Stimulation for Opioid Consumption After Gastrointestinal Laparoscopic Surgery

Start date: June 2, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to evaluate the effect of whole-process transcutaneous electrical acupoint stimulation on opioid consumption after gastrointestinal laparoscopic surgery. All subjects received conventional multimodal analgesia. On this basis, the experimental group received whole-process transcutaneous electrical acupoint stimulation, while the control group received corresponding false stimulation.

NCT ID: NCT06024187 Recruiting - Breast Neoplasms Clinical Trials

Cold Dissection Versus Electrocautery Dissection in Endoscopic Nipple-Sparing Mastectomy and Immediate Implant-Based Reconstruction: A Randomized Controlled Trial

Start date: May 1, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to analyze whether cold dissection can decrease the rate of ischemia necrosis and other complications and then increase the aesthetic outcomes compared to electrocautery. The purpose of this study is to analyze whether cold dissection can decrease the rate of ischemia necrosis and other complications and then increase the aesthetic outcomes compared to electrocautery.

NCT ID: NCT06024031 Not yet recruiting - Clinical trials for Acute Myeloid Leukemia

NAC for Promoting Hematopoietic Recovery in Patients With Acute Myeloid Leukemia After Chemotherapy

Start date: September 1, 2023
Phase: Phase 2
Study type: Interventional

This is a prospective single-arm clinical study to evaluate the role of NAC after chemotherapy among patients with AML can promote hematopoietic recovery and does not affect the remission rate of the leukemia.

NCT ID: NCT06023966 Recruiting - Gastric Cancer Clinical Trials

A Clinical Prospective Study to Validate a Risk Scoring Model for the HMGC After Curative Surgery

Start date: September 1, 2023
Phase:
Study type: Observational

A previous study of investigators established a risk scoring model for the occurrence of postoperative hepatic metastases in patients who underwent curative gastrectomy directly without neoadjuvant therapy. In order to further validate the clinical applicability of abovementioned model, investigators designed this prospective study, which also included patients who received neoadjuvant therapy before surgery, with the aim of exploring the applicability of the risk scoring model to this group of patients.

NCT ID: NCT06023875 Recruiting - Clinical trials for Head and Neck Squamous Cell Carcinoma

Neoadjuvant Cadonilimab in Combination With Cisplatin and Nab-paclitaxel in Resectable Head and Neck Squamous Cell Carcinoma

NCCCNRHNSCC
Start date: July 19, 2023
Phase: Phase 2
Study type: Interventional

This study is a single arm phase ll trial including 30 patients with T2N2-3M0、T3-4N0-3M0 (lll-V) head and neck squamous cell carcinoma (HNSCC) eligible forresection, who receive neo-adjvuant Cadonilimab combined with cisplatin and Nab.paclitaxel.This proposed study will evaluate the efficacy and safety of preoperativeadministration of Cadonilimab combined with chemotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC) who are about to undergo surgery.

NCT ID: NCT06023797 Completed - Lung Cancer Clinical Trials

Neoadjuvant Immunochemotherapy for Lung Cancer

Start date: January 2017
Phase:
Study type: Observational

We retrospectively analyzed lung cancer patients who had NAICT and surgery in the Department of Thoracic Surgery, Zhongshan Hospital. NAICT was defined as chemotherapy that included at one application of PD-1 inhibitor.

NCT ID: NCT06023784 Not yet recruiting - Atrial Fibrillation Clinical Trials

The Impact of LBBAP vs RVP on the Incidence of New-onset Atrial Fibrillation in Patients With Atrioventricular Block

Start date: September 30, 2023
Phase: N/A
Study type: Interventional

This is a single-center, randomized controlled study. The aim of this study is to compare the impact of left bundle branch area pacing versus traditional right ventricular pacing on the incidence of atrial fibrillation in patients with atrioventricular block.

NCT ID: NCT06023771 Recruiting - Acute Pancreatitis Clinical Trials

Invasive Intervention of Local Complications of Acute Pancreatitis

Start date: October 2023
Phase:
Study type: Observational

Strategies for invasive intervention in acute pancreatitis include sequential or combined use of multiple drainage and debridement modalities. The more widely used is the step-up approach, which requires an individualized and multidisciplinary (internal medicine, interventional radiology, endoscopy, surgery, critical care medicine, and nutritionists) approach. The available evidence from randomized controlled studies is from highly selected subject populations, and it is unclear whether the results can be applied to complex clinical situations in real clinics, and the optimal strategy for drainage of peripancreatic lesions in different patients still needs to be evaluated in the real world. This study intends to establish a prospective single-center cohort for real-world analysis to collect comprehensive clinic information and clinical outcomes, to evaluate the effectiveness and safety of existing intervention strategies, especially the timing and modality of interventions, in real-world clinical practice, and to explore the key factors affecting patient prognosis.